Setup, so nobody has to ask: WXT · KP · the Netherlands.
Both of these get recommended confidently by different people, which suggests neither is obviously right.
My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.
Is there a defensible reason to prefer one, or is this a coin flip?
More usefully, this is the question where methodology matters more than the conclusion.
Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.
To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.
Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Name the laboratory and the dates or the comparison cannot be reproduced.
edited 10 Apr 2025 by t_oyelaran — tightened the wording; no substantive change
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.
Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.
Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.
Price per milligram of measured peptide, not per milligram of label claim.
Stated carefully, a single member running three suppliers on one method is worth more than thirty members running one supplier each.
Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.
Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.
The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.
Use a fixed documentation checklist rather than an impression.
Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.
Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.
One laboratory, one method, one submission. Otherwise it is not a comparison.
In practice, ratings on this site are ours alone and are deliberately not reconciled with anyone else's.
Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.
Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.
The caveat is that a comparison is a snapshot of the lots compared, and lots change.
Compare content, not purity. Purity clusters and content does not.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.